Joe BN, Sickles EA. The evolution of breast imaging: past to present. Radiology. 2014;273:S23–44. https://doi.org/10.1148/radiol.14141233.

Article  PubMed  Google Scholar 

Mansi L, Rambaldi PF, Procaccini E, Gregorio FD, Laprovitera A, Pecori B, et al. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med. 1996;23:932–9. https://doi.org/10.1007/BF01084367.

Article  CAS  PubMed  Google Scholar 

Khalkhali I, Diggles LE, Taillefer R, Vandestreek PR, Peller PJ, Abdel-Nabi HH. Procedure guideline for breast scintigraphy. J Nucl Med. 1999;40:1233–5.

CAS  PubMed  Google Scholar 

Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, et al. Breast scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003;30:BP107–114. https://doi.org/10.1007/s00259-003-1354-3.

Article  PubMed  Google Scholar 

Sun Y, Wei W, Yang H-W, Liu J-L. Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2013;40:450–63. https://doi.org/10.1007/s00259-012-2279-5.

Article  PubMed  Google Scholar 

Hruska CB. Updates in molecular breast imaging. Semin Roentgenol. 2022;57:134–8. https://doi.org/10.1053/j.ro.2021.12.006.

Article  PubMed  Google Scholar 

Taillefer R. Clinical applications of 99mTc-sestamibi scintimammography. Semin Nucl Med. 2005;35:100–15. https://doi.org/10.1053/j.semnuclmed.2004.11.002.

Article  PubMed  Google Scholar 

Wahl RL. Quo vadis: PET and single-photon molecular breast imaging. J Nucl Med. 2016;57:3S-8S. https://doi.org/10.2967/jnumed.115.159202.

Article  CAS  PubMed  Google Scholar 

Mann RM, Cho N, Moy L. Breast MRI: state of the art. Radiology. 2019;292:520–36. https://doi.org/10.1148/radiol.2019182947.

Article  PubMed  Google Scholar 

Zhu Y, Zhang D, Wang X-N, Chen Y-N, Pan M-F, Guerrini S, et al. Diagnostic test of conventional ultrasonography combined with contrast-enhanced ultrasound in the subcategorization of suspicious Breast Imaging-Reporting and Data System (BI-RADS) 4 breast lesions. Transl Cancer Res. 2025;14:2066–77. https://doi.org/10.21037/tcr-2025-485.

Article  PubMed  PubMed Central  Google Scholar 

Groheux D, Vaz SC, Ulaner GA, Cook GJR, Woll JPP, Mann RM, et al. Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines. Eur J Nucl Med Mol Imaging. 2024;51:2701–5. https://doi.org/10.1007/s00259-024-06694-x.

Article  PubMed  Google Scholar 

O’Brien SR, Ward R, Wu GG, Bagheri S, Kiani M, Challa A, et al. Other novel PET radiotracers for breast cancer. PET Clin. 2023;18:557–66. https://doi.org/10.1016/j.cpet.2023.05.001.

Article  PubMed  Google Scholar 

Ulaner GA, Mankoff DA, Clark AS, Fowler AM, Linden HM, Peterson LM, et al. Summary: appropriate use criteria for estrogen receptor-targeted PET imaging with 16α-18F-fluoro-17β-fluoroestradiol. J Nucl Med. 2023;64:351–4. https://doi.org/10.2967/jnumed.123.265420.

Article  CAS  PubMed  Google Scholar 

Covington MF, Parent EE, Dibble EH, Rauch GM, Fowler AM. Advances and future directions in molecular breast imaging. J Nucl Med. 2022;63:17–21. https://doi.org/10.2967/jnumed.121.261988.

Article  CAS  PubMed  Google Scholar 

Fowler AM. A molecular approach to breast imaging. J Nucl Med. 2014;55:177–80. https://doi.org/10.2967/jnumed.113.126102.

Article  PubMed  Google Scholar 

Hruska CB, O’Connor MK. Nuclear imaging of the breast: translating achievements in instrumentation into clinical use. Med Phys. 2013;40:050901. https://doi.org/10.1118/1.4802733.

Article  PubMed  PubMed Central  Google Scholar 

Dibble EH, Hunt KN, Ehman EC, O’Connor MK. Molecular Breast Imaging in Clinical Practice. AJR Am J Roentgenol. 2020;215:277–84. https://doi.org/10.2214/AJR.19.22622.

Article  PubMed  Google Scholar 

Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med. 1990;31:1646–53.

CAS  PubMed  Google Scholar 

Moretti J-L, Hauet N, Caglar M, Rebillard O, Burak Z. To use MIBI or not to use MIBI? That is the question when assessing tumour cells. Eur J Nucl Med Mol Imaging. 2005;32:836–42. https://doi.org/10.1007/s00259-005-1840-x.

Article  PubMed  Google Scholar 

Del Vecchio S, Salvatore M. 99mTc-MIBI in the evaluation of breast cancer biology. Eur J Nucl Med Mol Imaging. 2004;31:88–96. https://doi.org/10.1007/s00259-004-1530-0.

Article  Google Scholar 

Urso L, Uccelli L, Boschi A, Schillaci O, Filippi L. Molecular imaging in cancer chemoresistance: what’s brewing? J Nucl Med. 2025;66:344–8. https://doi.org/10.2967/jnumed.124.268967.

Article  CAS  PubMed  Google Scholar 

Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48–58. https://doi.org/10.1038/nrc706.

Article  CAS  PubMed  Google Scholar 

Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 1993;53:977–84.

CAS  PubMed  Google Scholar 

Conners AL, Hruska CB, Tortorelli CL, Maxwell RW, Rhodes DJ, Boughey JC, et al. Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2012;39:971–82. https://doi.org/10.1007/s00259-011-2054-z.

Article  PubMed  Google Scholar 

Hruska CB, Corion C, de Geus-Oei L-F, Adrada BE, Fowler AM, Hunt KN, et al. SNMMI procedure standard/EANM practice guideline for molecular breast imaging with dedicated γ-cameras. J Nucl Med Technol. 2022;50:103–10. https://doi.org/10.2967/jnmt.121.264204.

Article  PubMed  PubMed Central  Google Scholar 

Dibble EH, Vaz SC, Arun B, Fowler AM, de Geus-Oei L-F, Hunt KN, et al. Appropriate use criteria for molecular breast imaging. J Nucl Med Technol. 2025;53:287–97. https://doi.org/10.2967/jnmt.125.270865.

Article  PubMed  Google Scholar 

Vaz SC, Corion CLS, Goeman J, Zeillemaker AM, Hezemans R, de Geus-Oei L-F, et al. Can molecular breast imaging with Tc-99m sestamibi safely rule out malignancy in pathologic nipple discharge? Clin Nucl Med. 2025;50:568–76. https://doi.org/10.1097/RLU.0000000000005851.

Article  PubMed  PubMed Central  Google Scholar 

Wahner-Roedler DL, Hruska CB, O’Connor MK, Phillips SW, Whaley DH, Johnson RE, et al. Molecular breast imaging for women presenting with a history of non-reproducible bloody nipple discharge and negative findings on routine imaging studies: a pilot study. J Surg Radiol. 2011;2:92–9.

Google Scholar 

Sumkin JH, Berg WA, Carter GJ, Bandos AI, Chough DM, Ganott MA, et al. Diagnostic performance of MRI, molecular breast imaging, and contrast-enhanced mammography in women with newly diagnosed breast cancer. Radiology. 2019;293:531–40. https://doi.org/10.1148/radiol.2019190887.

Article  PubMed  Google Scholar 

Mann RM, Athanasiou A, Baltzer PAT, Camps-Herrero J, Clauser P, Fallenberg EM, et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2022;32:4036–45. https://doi.org/10.1007/s00330-022-08617-6.

Article  PubMed  PubMed Central  Google Scholar 

Sorin V, Yagil Y, Yosepovich A, Shalmon A, Gotlieb M, Neiman OH, et al. Contrast-Enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. AJR Am J Roentgenol. 2018;211:W267–74. https://doi.org/10.2214/AJR.17.19355.

Article  PubMed  Google Scholar